menu
    • menu

    Company profile for Re-Vana Therapeutics

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Re-Vana Therapeutics is a 2016 start-up based on a technology developed at Queen’s University Belfast (QUB), Northern Ireland, UK. QUB has recently been recognized as the No. 1 university in the UK for their capacity to commercialize research*. The novel concept of photocrosslinking for ocular drug delivery was developed by Dr. Raj Thakur and his team. Re-Vana is developing photocrosslinked technologies for delivery of a wid...
    Re-Vana Therapeutics is a 2016 start-up based on a technology developed at Queen’s University Belfast (QUB), Northern Ireland, UK. QUB has recently been recognized as the No. 1 university in the UK for their capacity to commercialize research*. The novel concept of photocrosslinking for ocular drug delivery was developed by Dr. Raj Thakur and his team. Re-Vana is developing photocrosslinked technologies for delivery of a wide range of therapeutics that may dramatically extend the time between intravitreal, topical or other injectable routes of administrations to the eye.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Re-Vana Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    McClay Research Centre 97 Lisburn Road Belfast, BT9 7BL
    Telephone
    Telephone
    +44 (0) 28 9097 5814
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.revanatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/re-vana-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/re_vana

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Boehringer Links with Start-Up Re-Vana in $1B+ Eye Deal
    Boehringer Links with Start-Up Re-Vana in $1B+ Eye Deal

    29 Jul 2025

    // BIOSPACE

    https://www.biospace.com/business/boehringer-links-with-irish-drug-delivery-start-up-re-vana-in-1b-eye-deal

    BIOSPACE
    29 Jul 2025
    Share Share
    Re-Vana reels in $12M to develop sustained-release eye implants
    Re-Vana reels in $12M to develop sustained-release eye implants

    06 Dec 2022

    // FIERCEPHARMA

    https://www.fiercepharma.com/pharma/re-vana-reels-12m-develop-sustained-release-eye-implants

    FIERCEPHARMA
    06 Dec 2022
    Share Share
    RE-VANA THERAPEUTICS RAISES $11.9 MILLION IN SERIES A FINANCING
    RE-VANA THERAPEUTICS RAISES $11.9 MILLION IN SERIES A FINANCING

    30 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/re-vana-therapeutics-raises-11-9-million-in-series-a-financing-301690169.html

    PRNEWSWIRE
    30 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search